Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Cipla
Colorcon
Cerilliant
Chinese Patent Office
Cantor Fitzgerald
Moodys
McKinsey

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072163

« Back to Dashboard

NDA 072163 describes MAPROTILINE HYDROCHLORIDE, which is a drug marketed by Am Therap, Mylan, Watson Labs, and Watson Labs Teva, and is included in ten NDAs. It is available from one supplier. Additional details are available on the MAPROTILINE HYDROCHLORIDE profile page.

The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for 072163
Tradename:MAPROTILINE HYDROCHLORIDE
Applicant:Watson Labs Teva
Ingredient:maprotiline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 072163

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Jun 1, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Cipla
McKesson
US Department of Justice
Dow
Healthtrust
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.